Latest news
Loading news…
Barrier Therapeutics
ClosedOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring). Princeton, New Jersey, United States Founded 2002 51-100 employees For Profit
Barrier Therapeutics is a biopharmaceutical company focused on the discovery, development and commercialization.
Barrier Therapeutics was acquired by Stiefel in 2008 for $148M.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
0
Patents
2
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Delisted
- Ticker
- BTRX
- Exchange
- NASDAQ
- IPO date
- Apr 29, 2004
- Raised at IPO
- $75M
- Delisted
- Aug 6, 2008
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 2
- Patents granted
- 2
- Trademarks
- 0
- Top patent class
- Medical Or Veterinary Science; Hygiene
- IT spend
- $9M
Company Info
- Founded
- 2002
- Employees
- 51-100
- Operating status
- Closed
- Company type
- For Profit
- Org types
- company
- Founders
- 1
- News articles
- 3
- HQ
- Princeton, New Jersey, United States
- Region
- East Coast, Northeastern US
- Exit date
- Apr 29, 2004
- Closed
- Aug 5, 2008
Signals & Scores
- Heat score
- High
- Trend (7d)
- -1
- Trend (30d)
- -1.2
- Trend (90d)
- -0.7
Key People at Barrier Therapeutics
COO
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Barrier Therapeutics
Loading news…
FAQs about Barrier Therapeutics
People who checked this page also checked these
Browse the full Acquirezy directory.